Tuesday, June 2  •  12:00 – 1:00 PM EST

Register for Webinar
Brian Anderson

Brian Anderson
Formerly Vice President & Assistant General Counsel, IP Litigation
Allergan

Guy Donatiello

Guy Donatiello
Senior Vice President, Intellectual Property
Endo Pharmaceuticals

Shashank Upadhye

Shashank Upadhye
Partner
Upadhye Cwik LLP

Pearl T. L. Siew

Pearl T. L. Siew
Senior Vice President and Head, Intellectual Property
Eagle Pharmaceuticals, Inc.

Complimentary Webinar Highlights:

Join us for an informative complimentary webinar with esteemed members of the ACI’s Hatch-Waxman Series Advisory Board members on the state of the industry.

The coronavirus global pandemic has ushered in extraordinary roadblocks for the pharmaceutical industry – the very industry tasked with carving out a path forward for the world at large. Practitioners and litigants are forced to battle with unforeseen hurdles as they navigate FDA approval schedules, filing deadlines and launch dates.

Topics of discussion will include:

  • Understanding the potential long-term impact the coronavirus could have on supply chain disruption
  • Evaluating the impact of the conservation of resources on future investment in research and development
  • Reconciling court docket delays and Hatch-Waxman Act 30-month stays
  • Assessing the role of governmental intervention with respect to extensions
  • Identifying methods for overcoming mounting delays to pharmaceutical patent litigation caused by the coronavirus
  • Analyzing the impact of the coronavirus on deadlines before the USPTO and PTAB

With so much on the line, we’re evolving to help you address critical, high stakes developments impacting your organization’s path forward. Until we gather in person at the 14th Annual Paragraph IV Disputes in August, nothing stops connection and innovation. Register to this complimentary webinar today!